New Hepatitis Meds Are Saving Lives: Study

TUESDAY, Feb. 12, 2019 — New (and pricey) hepatitis C medicines, such as Harvoni and Sovaldi, are living up to their promise and greatly reducing patients’ odds for liver cancer and death, a new French study finds.
The news came as little surprise…
Source: Topamax